About VanEck Vectors Pharmaceutical ETF (PPH)

VanEck Vectors Pharmaceutical ETF (PPH) is an exchange-traded fund that seeks to replicate the performance of the MVIS US Listed Pharmaceutical 25 Index, which consists of the largest and most liquid US-listed pharmaceutical companies. With a focus on the pharmaceutical industry, PPH offers investors exposure to companies that are involved in the research, development, production, and distribution of pharmaceutical drugs and related products. The fund provides a convenient way for investors to gain broad exposure to the pharmaceutical sector without having to select individual stocks. PPH has a long-term track record of delivering consistent returns to investors and has become a popular choice for those seeking exposure to the pharmaceutical industry.

PPH has a market capitalization of approximately $XXX million, making it one of the largest pharmaceutical-focused ETFs in the market. The fund has an expense ratio of X.XX%, which is relatively low compared to other pharmaceutical ETFs. This makes PPH an attractive option for investors looking for cost-effective exposure to the pharmaceutical sector. PPH has a PEG ratio of X.XX, indicating that the fund may be undervalued relative to its earnings growth potential. This makes PPH an attractive investment option for those seeking growth opportunities in the pharmaceutical industry.